Shanghai ZJ Bio-Tech Co. Ltd. A - Asset Resilience Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has an Asset Resilience Ratio of 10.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai ZJ Bio-Tech Co. Ltd. A (688317) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Shanghai ZJ Bio-Tech Co. Ltd. A to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Shanghai ZJ Bio-Tech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Shanghai ZJ Bio-Tech Co. Ltd. A.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥403.46 Million | 10.88% |
| Total Liquid Assets | CN¥403.46 Million | 10.88% |
Asset Resilience Insights
- Moderate Liquidity: Shanghai ZJ Bio-Tech Co. Ltd. A has 10.88% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Shanghai ZJ Bio-Tech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai ZJ Bio-Tech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Shenzhen Lifotronic Technology Co
SHG:688389 |
Medical Devices | 2.53% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
Annual Asset Resilience Ratio for Shanghai ZJ Bio-Tech Co. Ltd. A (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Shanghai ZJ Bio-Tech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.24% | CN¥347.89 Million ≈ $50.91 Million |
CN¥3.76 Billion ≈ $550.76 Million |
+6.60pp |
| 2014-12-31 | 2.64% | CN¥5.28 Million ≈ $772.52K |
CN¥199.63 Million ≈ $29.21 Million |
-- |
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.